2-chloro-4-[(2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl)amino]benzoic acid

• ChemBase编号: 2454
• 分子式: C20H25ClN6O3
• 平均质量: 432.9039
• 单一同位素质量: 432.16766637
• SMILES: n1c(nc2n(C(C)C)cnc2c1Nc1ccc(c(Cl)c1)C(=O)O)N[C@H](C(C)C)CO
• Canonical SMILES: OC[C@@H](C(C)C)Nc1nc(Nc2ccc(c(c2)Cl)C(=O)O)c2c(n1)n(cn2)C(C)C
• InChI: InChI=1S/C20H25ClN6O3/c1-10(2)15(8-28)24-20-25-17(16-18(26-20)27(9-22-16)11(3)4)23-12-5-6-13(19(29)30)14(21)7-12/h5-7,9-11,15,28H,8H2,1-4H3,(H,29,30)(H2,23,24,25,26)/t15-/m0/s1
• InChIKey: ZKDXRFMOHZVXSG-HNNXBMFYSA-N

名称和登记号

名称

• IUPAC标准名: 2-chloro-4-[(2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl)amino]benzoic acid
• IUPAC传统名: purvalanol B; purvalanol
• 别名: Purvalanol; (2R)-2-[[6-[(3-Chloro-4-carboxyphenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol; NG 95; Purvalanol B

登记号

• CAS号: 212844-54-7
• MDL号: MFCD04118312
• PubChem SID: 160965905; 46505031
• PubChem CID: 448991

理论计算性质

JChem

• Acid pKa: 3.752279
• 质子受体: 8
• 质子供体: 4
• LogD (pH = 5.5): 1.8886467
• LogD (pH = 7.4): 0.42779335
• Log P: 3.2978978
• 摩尔折射率: 116.3567 cm^3
• 极化性: 43.6107 Å^3
• 极化表面积: 125.19 Å^2
• 可自由旋转的化学键: 8
• 里宾斯基五规则: true

ALOGPS 2.1

• Log P: 3.62
• LOG S: -3.82
• 溶解度: 6.62e-02 g/l

分子性质

理化性质

• 溶解度: DMSO: soluble37 mg/mL; H2O: insoluble
• 外观: solid

安全信息

• 德国WGK号: 3
• 个人保护装置: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• 保存温度: -20°C

产品相关信息

• 纯度: ≥97% (HPLC)
• 运输包装: dry ice
• Empirical Formula (Hill Notation): C20H25ClN6O3

详细说明

DrugBank - DB02733

Drug information: experimental

Sigma Aldrich - P5234

Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
Purvalanol B is a cyclin-dependent; 2,6,9-substituted kinase inhibitor.